Australia markets close in 2 hours 35 minutes

Universal Biosensors, Inc. (UBI.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.2800+0.0100 (+3.70%)
As of 10:09AM AEST. Market open.
Currency in AUD

Valuation measures4

Market cap (intra-day) 47.66M
Enterprise value 21.62M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)7.47
Price/book (mrq)1.09
Enterprise value/revenue 3.95
Enterprise value/EBITDA -1.53

Trading information

Stock price history

Beta (5Y monthly) 1.26
52-week change 3-64.94%
S&P500 52-week change 3-16.45%
52-week high 31.0400
52-week low 30.2200
50-day moving average 30.2878
200-day moving average 30.5996

Share statistics

Avg vol (3-month) 3287.33k
Avg vol (10-day) 3200.31k
Shares outstanding 5211.84M
Implied shares outstanding 6N/A
Float 8153.79M
% held by insiders 16.03%
% held by institutions 138.63%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)30 June 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)-386.80%

Management effectiveness

Return on assets (ttm)-22.95%
Return on equity (ttm)-42.03%

Income statement

Revenue (ttm)5.47M
Revenue per share (ttm)0.03
Quarterly revenue growth (yoy)-26.10%
Gross profit (ttm)2.11M
EBITDA -18.3M
Net income avi to common (ttm)-16.48M
Diluted EPS (ttm)-0.0770
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)31.56M
Total cash per share (mrq)0.15
Total debt (mrq)5.51M
Total debt/equity (mrq)12.64
Current ratio (mrq)3.98
Book value per share (mrq)0.21

Cash flow statement

Operating cash flow (ttm)-14.09M
Levered free cash flow (ttm)-10.95M